Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03109015
Title Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing (ASSET)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Institute Durham North Carolina 27705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field